Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:HHV-7
|
| gptkbp:caused_by |
gptkb:herpes
|
| gptkbp:clinical_trial |
herpes encephalitis
herpes keratitis herpes simplex virus type 1 herpes simplex virus type 2 |
| gptkbp:complications |
primary infection
secondary infection |
| gptkbp:family |
gptkb:Herpesviridae
|
| gptkbp:genus |
gptkb:Roseolovirus
gptkb:Cytomegalovirus gptkb:Lymphocryptovirus gptkb:Simplexvirus gptkb:Varicellovirus |
| gptkbp:healthcare |
gptkb:education
community awareness surveillance screening programs outbreak management |
| https://www.w3.org/2000/01/rdf-schema#label |
human herpesvirus
|
| gptkbp:is_protected_by |
vaccination
safe sex practices |
| gptkbp:performance |
gptkb:computer
|
| gptkbp:research |
genetic studies
therapeutic interventions vaccine development |
| gptkbp:restoration |
stress
immunosuppression |
| gptkbp:social_responsibility |
gptkb:genital_herpes
clinical examination serology chickenpox PCR test shingles high prevalence cold sores mononucleosis ubiquitous in humans |
| gptkbp:symptoms |
pain
itching blisters |
| gptkbp:transmission |
direct contact
vertical transmission asymptomatic shedding |
| gptkbp:treatment |
gptkb:drug
supportive care topical creams oral antivirals intravenous antivirals |
| gptkbp:type |
double-stranded DNA virus
|